An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP

AUTOR(ES)

Luciano, Randy L.

FONTE

The National Academy of Sciences

RESUMO

In herpes simplex virus, lytic replication is initiated by the viral transactivator VP16 acting with cellular cofactors Oct-1 and HCF-1. Although this activator complex has been studied in detail, the role of HCF-1 remains elusive. Here, we show that HCF-1 contains an activation domain (HCF-1AD) required for maximal transactivation by VP16 and its cellular counterpart LZIP. Expression of the VP16 cofactor p300 augments HCF-1AD activity, suggesting a mechanism of synergy. Infection of cells lacking the HCF-1AD leads to reduced viral immediate-early gene expression and lowered viral titers. These findings underscore the importance of HCF-1 to herpes simplex virus replication and VP16 transactivation.

Documentos Relacionados

• VP16 targets an amino-terminal domain of HCF involved in cell cycle progression.
• Herpes Simplex Virus Transactivator VP16 Discriminates between HCF-1 and a Novel Family Member, HCF-2
• Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP
• Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the in1814 linker insertion mutation.
• Truncation of the C-Terminal Acidic Transcriptional Activation Domain of Herpes Simplex Virus VP16 Renders Expression of the Immediate-Early Genes Almost Entirely Dependent on ICP0